Cornercap Investment Counsel’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,894
| Closed | -$991K | – | 151 |
|
|
2025
Q2 | $991K | Sell |
7,894
-217
| -3% | -$27K | 0.52% | 97 |
|
|
2025
Q1 | $1.11M | Sell |
8,111
-128
| -2% | -$18.3K | 0.58% | 85 |
|
|
2024
Q4 | $1.26M | Buy |
8,239
+1,174
| +17% | +$198K | 0.41% | 73 |
|
|
2024
Q3 | $1.37M | Buy |
+7,065
| New | +$1.48M | 0.41% | 78 |
|
|
2024
Q2 | – | Sell |
-3,599
| Closed | -$776K | – | 605 |
|
|
2024
Q1 | $776K | Buy |
+3,599
| New | +$843K | 0.12% | 316 |
|
|
2023
Q1 | – | Sell |
-4,991
| Closed | -$1.38M | – | 568 |
|
|
2022
Q4 | $1.38M | Sell |
4,991
-3,915
| -44% | -$1.11M | 0.24% | 104 |
|
|
2022
Q3 | $2.38M | Sell |
8,906
-30
| -0.3% | -$6.37K | 0.45% | 36 |
|
|
2022
Q2 | $1.82M | Buy |
8,936
+148
| +2% | +$30.3K | 0.32% | 79 |
|
|
2022
Q1 | $1.85M | Buy |
+8,788
| New | +$1.91M | 0.21% | 111 |
|
|
2021
Q4 | – | Sell |
-867
| Closed | -$245K | – | 541 |
|
|
2021
Q3 | $245K | Sell |
867
-140
| -14% | -$45.9K | 0.03% | 512 |
|
|
2021
Q2 | $349K | Sell |
1,007
-11,534
| -92% | -$3.49M | 0.04% | 496 |
|
|
2021
Q1 | $3.51M | Sell |
12,541
-3,096
| -20% | -$835K | 0.39% | 54 |
|
|
2020
Q4 | $4.64M | Sell |
15,637
-124
| -0.8% | -$32K | 0.66% | 17 |
|
|
2020
Q3 | $4.47M | Sell |
15,761
-918
| -6% | -$256K | 0.63% | 20 |
|
|
2020
Q2 | $4.46M | Sell |
16,679
-409
| -2% | -$123K | 0.72% | 14 |
|
|
2020
Q1 | $5.41M | Sell |
17,088
-999
| -6% | -$303K | 1.06% | 2 |
|
|
2019
Q4 | $5.37M | Sell |
18,087
-965
| -5% | -$268K | 0.72% | 14 |
|
|
2019
Q3 | $4.43M | Sell |
19,052
-1,004
| -5% | -$234K | 0.63% | 28 |
|
|
2019
Q2 | $4.69M | Sell |
20,056
-41
| -0.2% | -$9.47K | 0.62% | 29 |
|
|
2019
Q1 | $4.75M | Sell |
20,097
-55
| -0.3% | -$17.3K | 0.66% | 26 |
|
|
2018
Q4 | $6.06M | Sell |
20,152
-1,238
| -6% | -$395K | 0.94% | 5 |
|
|
2018
Q3 | $7.56M | Sell |
21,390
-365
| -2% | -$126K | 0.99% | 5 |
|
|
2018
Q2 | $6.31M | Sell |
21,755
-82
| -0.4% | -$23.1K | 0.9% | 11 |
|
|
2018
Q1 | $5.98M | Buy |
21,837
+51
| +0.2% | +$15.8K | 0.85% | 22 |
|
|
2017
Q4 | $6.94M | Sell |
21,786
-520
| -2% | -$167K | 0.95% | 13 |
|
|
2017
Q3 | $6.98M | Sell |
22,306
-67
| -0.3% | -$19.8K | 0.98% | 11 |
|
|
2017
Q2 | $6.07M | Sell |
22,373
-167
| -0.7% | -$44.2K | 1.02% | 14 |
|
|
2017
Q1 | $6.16M | Sell |
22,540
-490
| -2% | -$139K | 1.05% | 18 |
|
|
2016
Q4 | $6.53M | Sell |
23,030
-345
| -1% | -$102K | 1.13% | 16 |
|
|
2016
Q3 | $7.32M | Sell |
23,375
-980
| -4% | -$290K | 1.33% | 7 |
|
|
2016
Q2 | $5.89M | Sell |
24,355
-710
| -3% | -$187K | 1.12% | 31 |
|
|
2016
Q1 | $6.53M | Buy |
25,065
+305
| +1% | +$80.6K | 1.22% | 34 |
|
|
2015
Q4 | $7.58M | Buy |
+24,760
| New | +$7.11M | 1.44% | 23 |
|
Other funds holding BIIB
Cornercap Investment Counsel's BIIB Position: Q3 2025 in Review
Cornercap Investment Counsel sold out of Biogen (BIIB) in Q3 2025, closing a stake of 7,894 shares — an estimated $991K sold.
Cornercap Investment Counsel first reported a position in BIIB in Q4 2015 and held it in 33 quarters. The position peaked at $7.58M in Q4 2015. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Cornercap Investment Counsel reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Cornercap Investment Counsel sold 7,894 Biogen shares in Q3 2025, an estimated $991K.
- Cornercap Investment Counsel first reported a position in Biogen in Q4 2015 and held it in 33 quarters.
- Cornercap Investment Counsel's Biogen position peaked at $7.58M in Q4 2015.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Cornercap Investment Counsel's 13F filing for Q3 2025, filed 15 Oct 2025.